Table 1.
Demographics for radical retropubic and laparoscopic radical prostatectomy patients who completed follow-up quality of life sexual function and anxiety questions (N=350)
| Variable | Overall N = 350a |
|---|---|
| 1. PCa, prostate cancer; PSA, prostate-specific antigen; RRP, Radical retropubic prostatecomy. | |
| 2. a | |
| The sample median (minimum, 25th percentile, 75th percentile, maximum) is given for numerical variables, n (%) for categorical variables. | |
| M‘Age at treatment (years) | 63.8 (42.7, 59.0, 67.8, 78.1) |
| Marital status | |
| Married | 311 (89%) |
| Single | 14 (4%) |
| Separated/divorced | 22 (6%) |
| Widowed | 3 (1%) |
| Race—White | 315 (90%) |
| History of erectile dysfunction (Unknown in 40) | 147/310 (47%) |
| Diabetes | 31 (9%) |
| Family history of PCa | 99 (28%) |
| Preoperative PSA (Unknown in 7) | |
| <4 | 70 (20%) |
| 4–10 | 245 (71%) |
| >10–20 | 23 (7%) |
| >20 | 5 (2%) |
| Pretreatment Gleason score (missing in n = 1) | |
| 4–6 | 187 (54%) |
| 7 | 122 (35%) |
| 8–10 | 40 (11%) |
| Pathological Gleason score | |
| 6 | 127 (36%) |
| 7 | 191 (55%) |
| 8–10 | 32 (9%) |
| Treatment type | |
| RRP | 154 (44%) |
| Laproscopic | 196 (56%) |
| T stage (Unknown in 1) | |
| 1c | 2 (1%) |
| 2a,2b | 66 (19%) |
| 2c | 236 (68%) |
| 3a,3b | 45 (13%) |
| Prostatic capsule involvement (unknown in 4) | 69/346 (20%) |
| Positive margins (unknown in 1) | 99/349 (28%) |
| Seminal vesicle involvement (unknown in 2) | 20/348 (6%) |
| Nerve sparing | |
| No | 34 (10%) |
| Full | 291 (83%) |
| Partial | 25 (7%) |
| PSA 6–18 months post surgery (Missing in n = 49) | |
| 0–0.1 | 267 (89%) |
| >0.1–0.5 | 23 (8%) |
| >0.5–2 | 7 (2%) |
| >2–4 | 2 (1%) |
| >4–<10 | 1 (<1%) |
| >10 | 1 (<1%) |